The Full Story
MICA Biosystems was established as a spin-out from the University of Keele, United Kingdom with the ambitious goal of pioneering the use of biomagnetic technology to aid regenerative medicine and tissue engineering. The company has been operating since 2010 and is currently headquartered in Birmingham, United Kingdom.
The founders and visionaries behind MICA Biosystems, Dr. Jon Dobson and Prof. Alicia El Haj, are world leaders in the fields of biotechnology and biomedical applications having published 500+ articles on the topic between them. By bringing together interdisciplinary groups within biomedicine, physical sciences and engineering Dr. Dobson and Prof. El Haj have made it their ambition to drive the development of novel technologies and innovative new cell based therapies for use in the clinic.
Years of intensive research and development have led the company to the discovery of the innovative MICA technology that holds the promise of furthering clinical research as well as the becoming a widely available method of treatment for patients. The company is in the process of working with several leading clinicians and scientific institutions around the world to conduct a series of validation and feasibility studies of MICA technology in a variety of medical applications.
MICA Biosystems holds technology patents in the APAC, EMEA, and AMER regions.
MICA Biosystems’ mission is to unlock the potential of nanotechnology and stem cell therapies in both the clinical and research fields by allowing for controlled cell differentiation and mechanical stimulation, both in vivo and in vitro.
MICA Biosystems will enable a new approach to controlling cell behaviour with applications in tissue engineering and regenerative medicine, stem cell research, pharmaceutical screening, and therapeutic applications.